Microcourses

Our microcourses are 1.5-hour expert-led sessions that explore a range of immunological topics, offering trainees deeper insight into the field and its latest developments.

Held virtually, each session centers around a theme and features two speakers, each delivering a 30-minute presentation followed by a 15-minute Q&A.

2026


{{brizy_dc_image_alt imageSrc=

Feb 4 | Innate Immunity

From the bench to the field: harnessing ILC2s for ovarian cancer immunotherapy

Dr. Michele Ardolino, University of Ottawa

Type 2 Innate Lymphoid Cells in Cancer: Mechanisms and Therapeutic Implications

Dr. Nicolas Jacquelot, University of Calgary


Zoom link >

Add to calendar >

2025


{{brizy_dc_image_alt imageSrc=

Apr 30 | Microbiome and Immunity

Host-Microbiome Interactions: How the Ecosystems Within Us Influence Immunity and Inflammation

Dr. Lisa Osborne, University of British Columbia

Mucus, Microbes, and Shaping the Gut Environment

Dr. Lauren Davey, University of Victoria

{{brizy_dc_image_alt imageSrc=

Feb 3 | Vaccines and Infectious Diseases (Part 2)

Understanding how vaccines really work using systems immunology: The pathway to precision vaccinology

Dr. Manish Sadarangani, University of British Columbia

Dr. Amy Lee, Simon Fraser University

2024


{{brizy_dc_image_alt imageSrc=

Dec 3 | Vaccines and Infectious Diseases Part 1

Next-Generation RNA Vaccines

Dr. Anna Blakney, University of British Columbia

Lipid Nanoparticle Design from mRNA Vaccines to Therapeutics

Dr. Suiyang Liao, University of British Columbia

{{brizy_dc_image_alt imageSrc=

Jan 22 | Intersection between Stem Cell Products and ImmunoTherapies

Generating and targeting macrophages for cell and immune therapies in diabetes

Dr. Bruce Verchere, University of British Columbia

Engineering T cell development

Dr. Peter Zandstra, University of British Columbia

2023


{{brizy_dc_image_alt imageSrc=

Nov 21 | Advanced T-Cell Engineering for Cancer

Bioprocess Development and Devices for T-Cell Therapy Manufacturing

Dr. James Piret, University of British Columbia

Engineering more effective and accessible CAR T cells

Dr. Laura Evgin, University of British Columbia

{{brizy_dc_image_alt imageSrc=

Oct 21 | Immunometabolism

From bench to bedside: Immunometabolic engineering T cells as cancer cell therapies

Dr. Julian Lum, University of Victoria

Metabolic regulation of activation and cytokine production in macrophages

Dr. Ramon Klein Geltink, University of British Columbia

Apr 6 | Introduction to Immunotherapy

Engineering T cells to treat cancer: Local efforts in a global context

Dr. Brad Nelson, University of British Columbia

Regulatory T Cell Therapy

Dr. Megan Levings, University of British Columbia

{{brizy_dc_image_alt imageSrc=
{{brizy_dc_image_alt imageSrc=
{{brizy_dc_image_alt imageSrc=

© Copyright 2025 by ImmunoT & ImmunoE